APTO•benzinga•
Why Aptose Biosciences (APTO) Stock Is Down Over 40%
Summary
Aptose Biosciences shares are trading lower by 53.7% during Tuesday's session. The company announced it is going to delist from the Nasdaq.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 1, 2025 by benzinga